Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

NCT04960618 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Mycosis Fungoides
Mycosis Fungoides/Sezary Syndrome
Sezary Syndrome
Sézary
Advanced Mycosis Fungoides

Interventions

DRUG: Gemcitabine
DRUG: Pembrolizumab

Sponsor

Memorial Sloan Kettering Cancer Center